Rare diseases
Investigational molecules
Locations
Back to Greece33 clinical trials in Paleo Faliro, Greece. Every trial is listed in the EU Clinical Trials Register and updated daily.
Efficacy and Safety of Once‑Daily Oral ASC30 in Adults with Obesity or Overweight: A Phase III Randomized Placebo‑Controlled Trial
GreeceA Phase III Study of ASC30 Sodium for Weight Loss in Adults with Obesity or Overweight and Type 2 Diabetes
GreeceA study to assess the effect of elecoglipron alone and in combination with dapagliflozin on blood sugar control in adults with Type 2 diabetes
GreeceStudy of lunsekimig versus placebo in adults with inadequately controlled eosinophilic COPD
GreeceStudy of AZD6793 tablets to reduce flare-ups in adults with moderate to very severe chronic obstructive pulmonary disease (COPD)
GreeceGreeceStudy on the Effects of Budesonide, Glycopyrronium, and Formoterol Fumarate for Patients with Chronic Obstructive Pulmonary Disease (COPD)
GreeceStudy of Three Doses of Frevecitinib (KN-002) in Adults with Severe Asthma Not Controlled by Medium‑to‑High Dose Inhaled Steroid/LABA Therapy
GreeceMetronidazole, Bismuth Oxide and Tetracycline Hydrochloride Fixed‑Dose Combination vs Standard First‑line Therapy for Adults with Helicobacter pylori Infection
GreeceGB-0895 for Severe Uncontrolled Asthma in Adults and Adolescents
GreeceA study to evaluate the efficacy and safety of depemokimab and salbutamol sulfate in patients with chronic obstructive pulmonary disease and type 2 inflammation.
GreeceA study to evaluate the safety and effectiveness of AZD0292 in people aged 12 years and older with bronchiectasis and chronic Pseudomonas aeruginosa infection
GreeceThe busiest research cities in the country
What the registry says about research in the country
Extensive research focusing on chronic respiratory conditions, particularly investigating new therapeutic approaches for asthma and COPD management.
Multiple trials evaluating innovative inhaler medications and biological treatments to improve lung function and reduce disease progression.
Comprehensive studies examining treatments for Type 1 and Type 2 Diabetes, with particular attention to weight management and cardiovascular outcomes.
Innovative therapies being tested to improve glycemic control and address related metabolic conditions.
Critical investigations into heart failure prevention and cardiovascular risk reduction, particularly in patients with multiple comorbidities.
Studies evaluating novel drug combinations and their impact on cardiovascular safety and disease progression.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
